VHIR collaborates in the development of nanoGLA, an innovative nanotechnology therapy to treat Fabry disease. It has demonstrated high efficacy in preclinical studies, highlighting its effectiveness in addressing neurological manifestations.

A key initiative that connects researchers with a network of more than 20 external mentors who are experts in various fields within the ecosystem.

Members of the RBDCOV project, which involves VHIR, gathered at the Palau Macaya to review progress and achievements made during the final phase of the project.

Els ajuts, gairebé de tres milions d’euros en total, impulsen la formació de noves generacions de professionals en recerca i donen suport al desenvolupament de noves tecnologies.

Researchers from all over Europe gathered to kick off the SPM4.0 project, an innovative Marie Curie Skłodowska (MSCA-DN) doctoral network that promotes the development of autonomous Scanning Probe Microscopy with AI.

The Parc Taulí and Vall d’Hebron spin-off has raised €2.77 million in private and public funds, enabling it to complete the necessary clinical trials to obtain CE marking and bring this device to market.

Vall d'Hebron researchers have created a score based on multiple clinical variables and cardiac images, specific to women, to identify patients at risk of severe complications such as a heart attack or sudden death.

The sessions were aimed at establishing new collaborations to advance the prevention and treatment of this type of tumour.

A new consortium of leading organizations embarks on a groundbreaking project to enhance patient triage and healthcare delivery.

Over time, wild boars have approached the city of Barcelona and surrounding areas. As carriers of the hepatitis E virus, they are linked to a study identifying them as a potential source of transmission of this disease.

During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The Experimental Surgery Unit and the Preclinical Imaging Platform of VHIR will host several practical classes of the module "Reduction and Refinement in Experimental Design and Methodology," of the Master's in Laboratory Animal Science and Welfare

The communication is part of a study aimed at identifying the mechanisms of progression of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis, a rare disease that affects the kidneys.

The study on the effects of diesel particles on the heart has been recognized as the best research work from Spain at the association’s Scientific Sessions.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

The experience of our teaching staff and research groups, the commitment to professional development and the tutorial action plan are highlighted.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

This appointment is an international recognition of VHIR's immunodeficiency research.

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.

Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.

The conclusions from the 1st International Congress on Health Communication will provide the basis for a Guide to Health Communication, which will be share with the European University Hospital Alliance (EUHA).